STAT
SEPTEMBER 30, 2024
billion combined last year, compared with $4 billion in 2022. million in 2022. The heads of pharmaceutical companies and medical device firms continued to sit at the top as their patented products reaped the biggest windfalls. But the biggest names in health care still made $3.5
STAT
JANUARY 9, 2023
Cough medicine tainted with ethylene glycol that killed at least 19 children in Uzbekistan in late December 2022 has once again revealed lax oversight and regulation of pharmaceutical companies based in India. That preventable tragedy, which involves products made by Marion Biotech, based in Noida, India, echoes earlier cases.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JANUARY 4, 2024
The pharmaceutical company said Thursday that it has also signed a deal with Flagship-founded startup Cellarity to develop a new medicine for the fatty liver disease MASH, formerly known as NASH. These are the first two deals announced under a collaboration agreement Flagship and Novo Nordisk struck in 2022.
STAT
APRIL 28, 2023
After several quarters of promising to deliver concrete progress on key digital therapeutics projects, Swedish pharmaceutical company Orexo on Thursday reported the somber news that its efforts remained stalled. Orexo, which made almost all of its $60 million in 2022 revenues from U.S.
STAT
MARCH 29, 2023
As the health impacts of climate change become harder to ignore, biotechnology and pharmaceutical companies are facing increasing pressure from investors, employees, and government regulators to reduce their carbon emissions, and to make environmental sustainability a core part of their business. In the U.S., about 8.5%
STAT
JANUARY 10, 2024
This latest revision, known as the DSM-5-TR, was prepared between 2016 and 2019, and published in 2022. The researchers found that, of the 55 physicians with ties to a pharmaceutical company, 91% accepted food and beverages, and 69% received compensation for travel and consulting, according to the analysis published in the BMJ.
STAT
OCTOBER 20, 2023
which transformed itself from a stodgy underperformer into one of the world’s hottest pharmaceutical companies, said this week that the genetic medicine research center it plans to open in Boston in August will eventually employ twice as many workers as originally estimated. Eli Lilly and Co.,
Expert insights. Personalized for you.
363 
Let's personalize your content